by Mark Curtis | Nov 27, 2013
. Welcome to the regenerative medicine deal review for the month of November. Cytori Therapeutics and Lorem Vascular have teamed up to catalyze the commercialization of Cytori cell therapies using its proprietary Celution® System in Asia. There was also a notable deal...
by Stacey Johnson | Nov 15, 2013
. Sometimes too much choice can be a bad thing. It paralyzes you. I was flummoxed by the many options available to me in selecting what to feature on Right Turn this week. Then it struck me: I have the perfect item right under my nose (so to speak). CCRM just launched...
by Alessandra Pasut | Oct 15, 2013
> As scientists we’d like to think and even take a bit of pride knowing our research is as value-free as it could be, detached from any political, economical or societal forces and influences. Yet history teaches us how basic research discoveries, from...
by Ben Paylor | Oct 11, 2013
“Stem cell research is going to impact on the lives of all Canadians as we move to an era of new stem cell-based treatments for degenerative diseases. StemCellShorts helps to engage the public in understanding the science of stem cells and I have been delighted to be...
by Holly Wobma | Oct 9, 2013
> For anyone following the celebrity gossip of the stem cell field, you’ve probably come across one of our rising stars, the induced pluripotent stem cell (iPSC). Award winning and deemed to have loads of potential, each one of us can produce this type of cell. The...
by Mark Curtis | Oct 3, 2013
. I have recently joined the business development group at CCRM, as an analyst, and believe it would be useful to start compiling some recaps on clinical developments in the regenerative medicine (RM) and cell therapy industries to complement the other science-related...
Comments